Humanigen Study of GM-CSF Neutralization With CAR-T Therapy Accepted as Oral Presentation at the 2019 Transplantation & Cellular Therapy (TCT) Annual Meeting

Stock Information for Humanigen Inc.

Loading

Please wait while we load your information from QuoteMedia.